<?xml version="1.0" encoding="UTF-8"?><html>
   <div tagx="ui">s13063-015-0552-1</div>
   <div tagx="ji">1745-6215</div>
   <head>
      <div tagx="dochead">Study protocol</div>
      <div tagx="bibl">
         <div tagx="title">
            <p>Use of moxibustion to treat primary dysmenorrhea at two interventional times: study
               protocol for a randomized controlled trial
            </p>
         </div>
         <ul tagx="aug">
            <li tagx="au">
               <span tagx="snm">Yang</span>
               <span tagx="fnm">Jie</span>
               <span tagx="insr"></span>
               <a href="jenny_yang_jie@126.com">jenny_yang_jie@126.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Yu</span>
               <span tagx="fnm">Siyi</span>
               <span tagx="insr"></span>
               <a href="380895114@qq.com">380895114@qq.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Lao</span>
               <span tagx="fnm">Lixing</span>
               <span tagx="insr"></span>
               <a href="lxlao1@hku.hk">lxlao1@hku.hk</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Yang</span>
               <span tagx="fnm">Mingxiao</span>
               <span tagx="insr"></span>
               <a href="mingxiaoyang@hotmail.com">mingxiaoyang@hotmail.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Chen</span>
               <span tagx="fnm">JianPing</span>
               <span tagx="insr"></span>
               <span tagx="insr"></span>
               <a href="abchen@hku.hk">abchen@hku.hk</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Luo</span>
               <span tagx="fnm">Xiao</span>
               <span tagx="insr"></span>
               <a href="16959188@qq.com">16959188@qq.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Wang</span>
               <span tagx="fnm">Yongxia</span>
               <span tagx="insr"></span>
               <a href="825506684@qq.com">825506684@qq.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Chen</span>
               <span tagx="fnm">Xiangzhu</span>
               <span tagx="insr"></span>
               <a href="1143026181@qq.com">1143026181@qq.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Li</span>
               <span tagx="fnm">Juan</span>
               <span tagx="insr"></span>
               <a href="785939016@qq.com">785939016@qq.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Zhu</span>
               <span tagx="fnm">Lihua</span>
               <span tagx="insr"></span>
               <a href="zlhcdzy2012@163.com">zlhcdzy2012@163.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Zheng</span>
               <span tagx="fnm">Qianhua</span>
               <span tagx="insr"></span>
               <a href="zhengqianhua@gmail.com">zhengqianhua@gmail.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Hu</span>
               <span tagx="fnm">Youping</span>
               <span tagx="insr"></span>
               <a href="hypcdutcm@yeah.net">hypcdutcm@yeah.net</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Wu</span>
               <span tagx="fnm">Xi</span>
               <span tagx="insr"></span>
               <a href="wuxi403@126.com">wuxi403@126.com</a>
            </li>
            <li tagx="au">
               <span tagx="snm">Liang</span>
               <span tagx="fnm">Fanrong</span>
               <span tagx="insr"></span>
               <a href="acuresearch@126.com">acuresearch@126.com</a>
            </li>
         </ul>
         <ul tagx="insg">
            <li tagx="ins">
               <p>Chengdu University of Traditional Chinese Medicine, NO.37, Shierqiao Road, Jinniu
                  District, Chengdu 610072, Sichuan, China
               </p>
            </li>
            <li tagx="ins">
               <p>School of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam,
                  Hong Kong, China
               </p>
            </li>
         </ul>
         <span tagx="source">Trials</span>
         <span tagx="issn">1745-6215</span>
         <span tagx="pubdate">2015</span>
         <span tagx="volume">16</span>
         <span tagx="issue">1</span>
         <span tagx="fpage">35</span>
         <a href="http://www.trialsjournal.com/content/16/1/35">http://www.trialsjournal.com/content/16/1/35</a>
         <div tagx="note">Jie Yang and Siyi Yu contributed equally to this work.</div>
         <div tagx="xrefbib">
            <div tagx="pubidlist">
               <span tagx="pubid">10.1186/s13063-015-0552-1</span>
            </div>
         </div>
      </div>
      <div tagx="history">
         <span tagx="rec">
            <div tagx="date">
               <span tagx="day">19</span>
               <span tagx="month">7</span>
               <span tagx="year">2014</span>
            </div>
         </span>
         <span tagx="acc">
            <div tagx="date">
               <span tagx="day">6</span>
               <span tagx="month">1</span>
               <span tagx="year">2015</span>
            </div>
         </span>
         <span tagx="pub">
            <div tagx="date">
               <span tagx="day">30</span>
               <span tagx="month">1</span>
               <span tagx="year">2015</span>
            </div>
         </span>
      </div>
      <div tagx="cpyrt">
         <span tagx="year">2015</span>
         <div tagx="collab">Yang et al.; licensee BioMed Central.</div>
         <div tagx="note">This is an Open Access article distributed under the terms of the Creative Commons
            Attribution License (
            <a href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided
            the original work is properly credited. The Creative Commons Public Domain Dedication
            waiver (
            <a href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.
         </div>
      </div>
      <ul tagx="kwdg">
         <li tagx="kwd">Moxibustion</li>
         <li tagx="kwd">Primary dysmenorrhea</li>
         <li tagx="kwd">Intervention time</li>
         <li tagx="kwd">Efficacy</li>
         <li tagx="kwd">RCT</li>
         <li tagx="kwd">Study protocol</li>
      </ul>
      <div id="abstract" tag="abstract">
         <div id="">
            <div tagx="st">
               <h2>Abstract</h2>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Background</h3>
               </div>
               <p>Dysmenorrhea is a common menstrual complaint among adolescent girls and women of reproductive
                  age. The treatment of dysmenorrhea is typically selected from multidisciplinary options,
                  including complementary and alternative medicine such as acupuncture and moxibustion.
                  However, there are few published randomized controlled trials concerning moxibustion
                  treatment for dysmenorrhea. This trial aims to investigate the efficacy and safety
                  of moxibustion for primary dysmenorrhea, and to identify the optimal time of moxibustion
                  treatment for primary dysmenorrhea.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Methods/Design</h3>
               </div>
               <p>This protocol is for a randomized controlled trial in which the assessor and statistician
                  will be blinded. A total of 222 eligible patients with dysmenorrhea will be randomly
                  assigned to three groups in a 1:1:1 ratio as treatment group A (treated before menstruation
                  onset), treatment group B (treated at the onset of menstruation), or control group
                  C (waiting list group). The participants assigned to the treatment groups will receive
                  suspended moxibustion treatment at 
                  <i>Sanyinjiao</i> (SP6) and 
                  <i>Guanyuan</i> (CV4), while the waiting list group will not receive moxibustion treatment until
                  the completion of the study. The trial period will consist of three baseline menstrual
                  cycles, three menstrual cycles of treatment, and three menstrual cycles in the follow-up
                  period. The primary outcome will be measured by changes in the Cox Menstrual Symptom
                  Scale and the secondary outcomes will be measured using the Visual Analogue Scale,
                  Cox Retrospective Symptom Scale, diary entries, the Self-rating Depression Scale,
                  and the Self-rating Anxiety Scale. The safety of moxibustion will be assessed at every
                  visit.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Discussion</h3>
               </div>
               <p>This trial aims to assess the effectiveness and safety of moxibustion for primary
                  dysmenorrhea, as well as to determine whether the optimal time of treatment for primary
                  dysmenorrhea in clinical practice is before or after the onset of menstrual pain.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h3>Trial registration</h3>
               </div>
               <p>Chinese Clinical Trial Register: 
                  <a href="ChiCTR-TRC-14004627">ChiCTR-TRC-14004627</a>, registered on 9 May 2014.
               </p>
            </div>
         </div>
      </div>
   </head>
   <div id="">
      <div tagx="st">
         <h2>Background</h2>
      </div>
      <p>Dysmenorrhea is a common menstrual complaint among adolescent girls and women of reproductive
         age 
         <span tagx="abbrgrp">
            <span tagx="abbr">1</span>
         </span>. It usually consists of two subcategories: primary and secondary dysmenorrhea. The
         focus of this paper is primary dysmenorrhea (PD), which is defined as painful menses
         in women with normal pelvic anatomy. Studies using different measurements have reported
         the prevalence of PD as between 20 and 90% of adolescent girls 
         <span tagx="abbrgrp">
            <span tagx="abbr">2</span>
         </span>. An Australian study found the prevalence of dysmenorrhea varied between 16 and 91%,
         with symptoms becoming severely painful in 2 to 29% of the women studied 
         <span tagx="abbrgrp">
            <span tagx="abbr">3</span>
         </span>.
      </p>
      <p>Dysmenorrhea has a significant impact on women’s lives and represents a substantial
         public health burden 
         <span tagx="abbrgrp">
            <span tagx="abbr">4</span>
         </span>-
         <span tagx="abbrgrp">
            <span tagx="abbr">6</span>
         </span>. Several studies have shown that female individuals with dysmenorrhea report that
         it affects their academic performance and social and sporting activities, which is
         a distressing finding given the availability of effective medications 
         <span tagx="abbrgrp">
            <span tagx="abbr">7</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">8</span>
         </span>. Nonsteroidal anti-inflammatory drugs are widely used as first-line therapy for women
         with dysmenorrhea 
         <span tagx="abbrgrp">
            <span tagx="abbr">9</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">10</span>
         </span>. However, in some women the side effects may not be well tolerated or the pain relief
         provided may be inadequate. Therefore, a large number of patients with PD are turning
         to complementary and alternative medicine such as acupuncture and moxibustion 
         <span tagx="abbrgrp">
            <span tagx="abbr">11</span>
         </span>.
      </p>
      <p>Moxibustion is widely used in Asian countries as a part of Traditional Chinese Medicine
         (TCM). It is a thermal treatment that involves placing ignited material (usually 
         <i>Artemisia vulgaris</i>) near acupuncture points to cause a warm and painless sensation 
         <span tagx="abbrgrp">
            <span tagx="abbr">12</span>
         </span>. Moxibustion is used to regulate the meridians and visceral organs of the human body
         
         <span tagx="abbrgrp">
            <span tagx="abbr">13</span>
         </span>. Suspended moxibustion is commonly used, which refers to the application of a burning
         moxa stick over the acupuncture points from a distance. In TCM, dysmenorrhea is etiologically
         caused by the stagnated blood or 
         <i>Qi</i> circulation in the uterus. The pathological factors are mostly dampness, blood stasis,
         and 
         <i>Qi</i> obstructions. Moxibustion as a therapy features on the effect of heat and 
         <i>Artemisia argyi</i>, and thus can improve blood circulation in the uterus and its surrounding veins,
         and also help to absorb local pathological discharges in patients with PD. It is considered
         effective in resolving blood stagnation, 
         <i>Qi</i> stagnation, and discomposing cold-damp coagulation, leading to an improved health
         state 
         <span tagx="abbrgrp">
            <span tagx="abbr">14</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">15</span>
         </span>. Clinical trials and systematic reviews have evaluated the effect of moxibustion
         for conditions including dysmenorrhea 
         <span tagx="abbrgrp">
            <span tagx="abbr">16</span>
         </span>, breech presentation 
         <span tagx="abbrgrp">
            <span tagx="abbr">17</span>
         </span>, ulcerative colitis 
         <span tagx="abbrgrp">
            <span tagx="abbr">18</span>
         </span>, stroke 
         <span tagx="abbrgrp">
            <span tagx="abbr">19</span>
         </span>, menopausal hot flashes 
         <span tagx="abbrgrp">
            <span tagx="abbr">20</span>
         </span>, and constipation 
         <span tagx="abbrgrp">
            <span tagx="abbr">21</span>
         </span>.
      </p>
      <p>Since ancient times, TCM has prescribed acupuncture and moxibustion to treat dysmenorrhea.
         Acupuncture stimulation, which involves thrusting or twisting needles, results in
         various biochemical reactions that can have effects throughout the body; moxibustion
         uses heat stimulation at various temperatures, from mild skin warmth to tissue damage
         caused by burning. This heat stimulation can yield inflammatory responses and induce
         vasodilation by releasing mediators such as histamine and substance P around the site
         of moxibustion therapy 
         <span tagx="abbrgrp">
            <span tagx="abbr">22</span>
         </span>,
         <span tagx="abbrgrp">
            <span tagx="abbr">23</span>
         </span>. According to TCM, the treatment of PD in clinical practice is usually started before
         menstruation. Several studies have used different time sequences of acupressure in
         dysmenorrhea to seek evidence-based medical proof regarding the appropriate point
         selection and timing of intervention in PD 
         <span tagx="abbrgrp">
            <span tagx="abbr">24</span>
         </span>. Unfortunately, clinical trials regarding the optimal time of moxibustion treatment
         intervention are lacking.
      </p>
      <p>This is a protocol for a randomized controlled trial (RCT) that aims to assess the
         efficacy and safety of moxibustion, and to determine whether the optimal time of treatment
         for PD is preventively or after menstrual pain begins.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Methods/Design</h2>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Setting</h3>
         </div>
         <p>This RCT will be conducted in a single center, with the assessor and statistician
            blinded to treatment allocation. A total of 222 patients diagnosed with PD in accordance
            with the Clinical Guidelines of Primary Dysmenorrhea by the Society of Obstetricians
            and Gynecologists of Canada will be enrolled in this trial 
            <span tagx="abbrgrp">
               <span tagx="abbr">25</span>
            </span>. The whole treatment process will be carried out in the Third Teaching Hospital of
            Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Patients</h3>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Recruitment strategies</h4>
            </div>
            <p>There will be three strategies for PD patient recruitment. First, participants will
               be recruited from the outpatient and inpatient department of the Third Teaching Hospital
               of Chengdu University of TCM. Second, printed recruitment posters will be distributed
               in public clinics and nearby communities. Third, advertisements will be published
               in the campuses of Chengdu University of TCM, Sichuan University, Southwest University
               of Nationalities and Southwest Universities of Finance and Economics, and Sichuan
               Vocational and Technical College of Communications.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Inclusion criteria</h4>
            </div>
            <p>Participants meeting the following criteria will be included:</p>
            <p>1. Aged from 18 to 30 years without history of delivery,</p>
            <p>2. Normal menstrual cycle (28 ± seven days) during the last three months,</p>
            <p>3. Diagnosed with PD according to the Primary Dysmenorrhea Consensus Guidelines 
               <span tagx="abbrgrp">
                  <span tagx="abbr">25</span>
               </span>,
            </p>
            <p>4. Diagnosed with the TCM pattern of stagnation of 
               <i>Qi</i> and blood, or retention of cold-damp coagulation (see Table 
               <span tagx="tblr">1</span>) 
               <span tagx="abbrgrp">
                  <span tagx="abbr">26</span>
               </span>,
               
            </p>
            <table>
               <div tagx="title">
                  <p>Table 1</p>
               </div>
               <caption>
                  <p>
                     <b>Traditional Chinese medicine pattern differentiation protocol for women with primary
                        dysmenorrhea
                     </b>
                  </p>
               </caption>
               <tgroup>
                  <colspec></colspec>
                  <colspec></colspec>
                  <thead>
                     <tr>
                        <td>
                           <p>
                              <b>Diagnostic patterns</b>
                           </p>
                        </td>
                        <td>
                           <p>
                              <b>Items</b>
                           </p>
                        </td>
                     </tr>
                  </thead>
                  <tbody>
                     <tr>
                        <td>
                           <p>
                              <b>Diagnostic pattern 1</b>
                           </p>
                        </td>
                        <td></td>
                     </tr>
                     <tr>
                        <td>
                           <p>Stagnation of 
                              <i>Qi</i> and blood
                           </p>
                        </td>
                        <td>
                           <p>Pain: distended, stabbing abdominal pain before or during the period aggravated by
                              pressure.
                           </p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Menstruation: dark purplish in color, clotty and hesitant or scanty in flow, pain
                              relieved after clots discharged.
                           </p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Accompanying symptoms: distending in breasts, mood swings.</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Tongue: purplish.</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Pulse: wiry.</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>
                              <b>Diagnostic pattern 2</b>
                           </p>
                        </td>
                        <td>
                           <p>Pain: distended, stabbing abdominal pain before or during the period, favorably to
                              warmth, lower back pain.
                           </p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Retention of cold-damp coagulation</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Menstruation: dark purplish in color, clotty and hesitant in flow, pain relieved after
                              clots discharged.
                           </p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Accompanying symptoms: distending in breasts, mood swings, and aversion to cold.</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Tongue: pale and white greasy tongue coating.</p>
                        </td>
                     </tr>
                     <tr>
                        <td>
                           <p>Pulse: deep and slow.</p>
                        </td>
                     </tr>
                  </tbody>
               </tgroup>
            </table>
            <p>5. Menstrual pain score of over 40 mm on the Visual Analogue Scale (VAS),</p>
            <p>6. Agree to keep a dysmenorrhea diary during the study period, and</p>
            <p>7. Agree with all procedures in this trial by signing a written informed consent form.</p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Exclusion criteria</h4>
            </div>
            <p>Participants meeting one or more of the following criteria will be excluded:</p>
            <p>1. Secondary dysmenorrhea caused by endometriosis, uterine myoma, endometrial polyps,
               pelvic inflammatory disease, or other gynecological problems confirmed by a gynecological
               abdominal ultrasound B examination;
            </p>
            <p>2. Serious contraindications (for example, a life-threatening condition or progressive
               central nervous disorder);
            </p>
            <p>3. Any other condition that the investigator judges as likely to make the patient
               unable to complete, comply, or unsuitable for the study;
            </p>
            <p>4. Uncontrolled diagnosed psychiatric disorders;</p>
            <p>5. Intent to have a baby during any period of the trial;</p>
            <p>6. Having taken antidepressants, anti-serotonin, barbiturates, or psychotropic drugs
               in the previous two weeks; or
            </p>
            <p>7. Currently receiving or having received any other treatment for PD in the previous
               three months.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Sample size</h4>
            </div>
            <p>A previous study found that the mean on the Cox Menstrual Symptom Scale (CMSS) of
               PD patients after moxibustion was 1.62 
               <span tagx="abbrgrp">
                  <span tagx="abbr">24</span>
               </span>. The average CMSS values of subjects in the proposed study, with the square of standard
               deviation, are expected to be 1.7, 1.9, and 2.5 for patients treated with moxibustion
               before menstruation, those treated at the time of menstrual onset, and the waiting
               list group, respectively. In this case, the three groups are set with the ratio of
               1:1:1 as the statistical power is 0.90 and the significance level is 0.05. The sample
               size was estimated by One Way ANOVA Power Analysis (11th edition, NCSS, LLC, Utah,
               United States) in NCSS-PASS (11th edition, NCSS, LLC, Utah, United States). After
               the estimation, the effect size is 0.2266 with 64 patients in each group and 192 patients
               in total. Therefore, there should ideally be 222 patients in total, with each group
               containing no less than 74 patients, estimating a dropout rate is 15%.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Ethics</h3>
         </div>
         <p>This study protocol was reviewed and approved by the Institutional Review Board of
            the Teaching Hospital of Chengdu University of Traditional Chinese Medicine in February
            2014 (approval number: 2013KL-034). The present study was financially supported by
            the National Natural Science Foundation of China and the trial was registered in Chinese
            Clinical Trials Registry with the identifier number ChiCTR-TRC-14004627. Prior to
            undertaking any study-related procedures, all participants will provide written informed
            consent.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Procedure</h3>
         </div>
         <p>An independent assessor will initially assess each potential participant according
            to the inclusion and exclusion criteria. After completing a screening test, participants
            will enter a baseline period of three months (three menstrual cycles) without moxibustion
            treatment, during which they will be asked to record menstrual pain and use of acute
            medication in a dysmenorrhea diary.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Randomization</h3>
         </div>
         <p>After participants have completed a baseline evaluation, eligible subjects will be
            randomly classified into three groups: treatment group A (treated before menstruation),
            treatment group B (treated as the onset of menstruation), and control group C (waiting
            list group). A computer-generated, blocked random allocation sequence will be generated
            with SAS software (Version 9.1, SAS Institute Inc., NC, United States). Another research
            coordinator who is not involved with data collection will provide the random number
            and group assignment immediately to the independent assessor in opaque, sealed envelopes.
            This procedure guarantees that randomization concealment is adequate, and not influenced
            by the acupuncturists or participants. Random allocation will be performed after the
            first visit to participants who provide informed consent and meet the inclusion criteria.
            If a participant is eligible to be included in the study, the researcher will open
            the corresponding envelope in front of the participant. The envelopes will be opened
            only after the enrolled participants have completed all baseline assessments.
         </p>
         <p>Figure 
            <div tagx="figr">1</div> summarizes the design of the study and Table 
            <span tagx="tblr">2</span> outlines the measures used in the trial. The duration of the study for every participant
            will be nine menstrual cycles, including three menstrual cycles in the baseline, treatment,
            and follow-up periods, respectively.
            
            
         </p>
         <div tagx="fig">
            <div tagx="title">
               <p>Figure 1</p>
            </div>
            <caption>
               <p>Flow chart of the trial. </p>
            </caption>
            <div tagx="text">
               <p>
                  <b>Flow chart of the trial.</b> Participants with a diagnosis of primary dysmenorrhea will be recruited at the Third
                  Teaching Hospital of Chengdu University of Traditional Chinese Medicine. All participants
                  should endure a baseline period of three menstrual cycles and inappropriate participants
                  will be excluded. A total of 222 participants will be randomized to three groups:
                  treatment group A (treated before the menstruation), treatment group B (treated at
                  the onset of menstruation), or control group C (waiting list group) in a 1:1:1 ratio.
                  The trial period will consist of three baseline menstrual cycles, three menstrual
                  cycles of treatment, and three menstrual cycles in the follow-up period, and the outcome
                  will be measured at every visit.
               </p>
            </div>
            <div tagx="graphic"></div>
         </div>
         <table>
            <div tagx="title">
               <p>Table 2</p>
            </div>
            <caption>
               <p>
                  <b>Study design schedule</b>
               </p>
            </caption>
            <tgroup>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <colspec></colspec>
               <thead>
                  <tr>
                     <td>
                        <p>
                           <b>Period</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Baseline</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Inclusion</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Treatment</b>
                        </p>
                     </td>
                     <td>
                        <p>
                           <b>Follow-up</b>
                        </p>
                     </td>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>
                        <p>Visit</p>
                     </td>
                     <td></td>
                     <td>
                        <p>1</p>
                     </td>
                     <td>
                        <p>2</p>
                     </td>
                     <td>
                        <p>3</p>
                     </td>
                     <td>
                        <p>4</p>
                     </td>
                     <td>
                        <p>5</p>
                     </td>
                     <td>
                        <p>6</p>
                     </td>
                     <td>
                        <p>7</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Menstrual cycle</p>
                     </td>
                     <td>
                        <p>−3 month</p>
                     </td>
                     <td>
                        <p>0 month</p>
                     </td>
                     <td>
                        <p>1 month</p>
                     </td>
                     <td>
                        <p>2 month</p>
                     </td>
                     <td>
                        <p>3 month</p>
                     </td>
                     <td>
                        <p>4 month</p>
                     </td>
                     <td>
                        <p>5 month</p>
                     </td>
                     <td>
                        <p>6 month</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Patients</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Inclusion and exclusion criteria</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Informed consent</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Physical examination</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Medical history</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Comorbidities</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Outcomes</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>CMSS</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>VAS</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>RSS</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>SDS and SAS</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Dysmenorrhea diary</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>PGF2a, PGE2</p>
                     </td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Gynecological abdominal ultrasound B</p>
                     </td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Trial evaluation</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Patient’s compliance</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Reasons for dropout or withdrawals</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
                  <tr>
                     <td>
                        <p>Adverse events</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                  </tr>
                  <tr>
                     <td>
                        <p>Safety evaluation</p>
                     </td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td></td>
                     <td>
                        <p>√</p>
                     </td>
                  </tr>
               </tbody>
            </tgroup>
         </table>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Blinding</h3>
         </div>
         <p>Double blinding of the clinician and patient is unfeasible owing to the unique nature
            of moxibustion operations. However, to ensure the integrity of the trial, the researchers
            will not assess the efficacy of treatment to avoid misleading the patients and inducing
            potential impacts on the compliance and outcome measurements. The therapist, the assessors
            of therapeutic effect, the data manager, and the statistician will be separated. Moreover,
            according to the principle of blinding, only patients allocated to the waiting list
            group will be told to wait for free treatments at the end of the study; allocation
            information will be strictly withheld from patients in the other two groups.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Interventions</h3>
         </div>
         <p>Acupuncturists must receive a license from the Ministry of Health of the People’s
            Republic of China and take an educational course to ensure their strict adherence
            to and familiarity with the study before they become eligible to treat patients in
            this study. Those participants allocated to a treatment group will be requested to
            attend (with their partner or support person if available) a training course and demonstration
            session by their tutors. The training course involves advice, demonstration of moxibustion,
            and instructions on how to do moxibustion safely at home. The woman or her partner
            or support person will be trained to light the moxibustion sticks and to hold an individual
            stick 2.5 to 3 cm above the two acupoints (SP6 and CV4). The participants will be
            told not to make the acupoints uncomfortable during treatment. They will be requested
            to perform this treatment for five to 10 minutes on each acupoint once a day for five
            to seven consecutive days, and will be supplied with sufficient moxibustion sticks
            to do so in each treatment period.
         </p>
         <div id="">
            <div tagx="st">
               <h4>Rationale for selection of acupoints</h4>
            </div>
            <p>The moxibustion treatment protocol to be used is consistent with the principles of
               traditional moxibustion theories. These principles state that the most common causes
               of dysmenorrhea in TCM are blood stagnation and cold-damp coagulation in the uterus.
               According to previous surveys and expert consultations, 
               <i>Sanyinjiao</i> (SP6) and 
               <i>Guanyuan</i> (CV4) are the most common acupoints used in PD treatment. SP6 is the convergent point
               of the spleen, liver, and kidney meridians according to TCM, and is closely related
               to the lower abdomen and uterus 
               <span tagx="abbrgrp">
                  <span tagx="abbr">27</span>
               </span>. This makes SP6 one of the most commonly used points for gynecologic indications
               in clinical practice, especially for alleviating dysmenorrhea. The CV4 point in the
               conception vessel meridian is known as the root of vital 
               <i>Qi</i>, and can exert a regulatory effect on the uterus because of its role of providing
               power to vital movement. Moxibustion at CV4 can treat dysmenorrhea because of its
               function of warming the conception vessel meridian, tonifying vital 
               <i>Qi</i>, and promoting blood circulation to remove blood stasis.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Treatment group A (treated before menstruation)</h4>
            </div>
            <p>Group A will be treated five days before expected menstrual onset and treatment will
               continue until menstruation begins. However, the subjects’ menstrual cycles may change
               and so the actual period of treatment will be five to seven days. The treatment will
               be the application of a moxa stick (herbal preparation with 
               <i>Artemisia vulgaris</i>, Z32021062, Oriental Moxa Co., Suzhou, China) at acupoints SP6 and CV4 to patients
               in a supine position. The moxa roll is prepared by wrapping mugwort wool (herbal medicines
               may be mixed in it) with a piece of a paper. It is cylindrical, 1.5 cm in diameter,
               and 20 cm in length. A lighted moxa roll will be held 2.5 to 3 cm above the acupoint
               and moved upwards and downwards, to the left and right, or around. The patient should
               feel warmth but not scorching heat. Each point will be treated with moxibustion for
               five to 10 minutes.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Treatment group B (treated within menstrual period)</h4>
            </div>
            <p>Group B treatment will start as soon as menstruation onsets, continuing for five consecutive
               days. The selection of acupoints and the procedure will be exactly the same as described
               above for treatment group A.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Control group C (waiting list group)</h4>
            </div>
            <p>Participants in this group will receive no moxibustion-related intervention while
               the trial is in process. The subjects in this group will be asked to maintain their
               normal lifestyle, including diet, exercise, and workload. At the end of the trial,
               if participants in group C would like to be treated with moxibustion, we will offer
               free moxibustion treatment five times monthly for three menstrual cycles.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Outcome assessments</h3>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Primary outcome measurement</h4>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Cox Menstrual Symptom Scale (CMSS)</h5>
               </div>
               <p>The CMSS has been widely used for integrally evaluating patients’ symptoms 
                  <span tagx="abbrgrp">
                     <span tagx="abbr">28</span>
                  </span>. The scale consists of 17 items or symptoms. In the severity evaluation, each symptom
                  is scored via five levels: a score of 0 denotes that the symptom is not noticeable;
                  one denotes it as slightly bothersome; two denotes it as moderately bothersome; three
                  denotes it as severely bothersome; and four denotes it as very severely bothersome.
                  In the duration evaluation, each symptom is scored in five grades: a score of 0 denotes
                  that the symptom did not occur; one denotes that it lasted less than three hours;
                  two denotes that it lasted between three and seven hours; three denotes that it lasted
                  an entire day; and four denotes that it lasted several days. The CMSS will be used
                  in each of the three menstrual cycles of treatment and the three menstrual cycles
                  during the follow-up period.
               </p>
            </div>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Secondary outcome measurements</h4>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Visual Analogue Scale</h5>
               </div>
               <p>The severity of menstrual pain will be measured with the VAS, a 100-mm horizontal
                  line with endpoints from no pain on the far left to the worst possible pain on the
                  far right. The VAS is scored by measuring in millimeters the distance from the side
                  marked no pain to the edge of the mark made by the patient. Possible scores range
                  from a minimum of 0 to a maximum of 100 mm, as participants will be asked to indicate
                  a perception of pain intensity scored from one to 100. The VAS will be used during
                  baseline measurements and during the first, second, third, fourth, fifth, and sixth
                  menstrual cycle after inclusion.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Cox Retrospective Symptom Scale</h5>
               </div>
               <p>The Cox Retrospective Symptom Scale (RSS) is a measurement of menstrual symptoms that
                  has been shown to have high reliability, validity, and sensitivity 
                  <span tagx="abbrgrp">
                     <span tagx="abbr">29</span>
                  </span>. It gives two scores: a Total Frequency Ratings score (RSS COX1) and an Average Severity
                  Ratings score (RSS COX2). Lower scores indicate better health. The RSS will be used
                  before treatment to assess the baseline condition of the patient.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Dysmenorrhea diary</h5>
               </div>
               <p>The women will be provided with dysmenorrhea diaries to record the specific time of
                  menstrual pain attacks, the duration of dysmenorrhea, the associated phenomena, and
                  any medication used. This information will be recorded daily during every menstrual
                  cycle of the three study periods. All patients will be carefully instructed on how
                  to use this diary to rate their symptoms. The dysmenorrhea diary will be used during
                  baseline measurements and during the first, second, third, fourth, fifth, and sixth
                  menstrual cycle after inclusion.
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Self-rating Depression Scale</h5>
               </div>
               <p>The Self-rating Depression Scale (SDS) is a 20-item self-reporting questionnaire on
                  the symptoms of depression. Subjects rate each item according to how they felt during
                  the preceding seven days. Item responses are ranked from one to four. The sum of the
                  20 items produces a score between 20 and 80, with a score of greater than 40 suggesting
                  clinically relevant depression 
                  <span tagx="abbrgrp">
                     <span tagx="abbr">30</span>
                  </span>. The SDS will be used on the day when menstruation ends in the last month of the
                  baseline period, and in the fourth menstrual cycle after inclusion (after completion
                  of three sessions of treatment).
               </p>
            </div>
            <div id="">
               <div tagx="st">
                  <h5>Self-rating Anxiety Scale</h5>
               </div>
               <p>The Self-rating Anxiety Scale (SAS) has been widely used in research and in clinical
                  practice for the detection of anxiety 
                  <span tagx="abbrgrp">
                     <span tagx="abbr">31</span>
                  </span>. It also consists of 20 items rated on numerical values of one to four. The total
                  SAS score may vary from 20 (no anxiety at all) to 80 (severe anxiety), with a value
                  of greater than 40 suggesting the presence of a clinically relevant anxiety disorder.
                  The SAS will be used on the day when menstruation ends in the last month of the baseline
                  period, and in the fourth menstrual cycle after inclusion (after completion of three
                  treatment sessions).
               </p>
            </div>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Follow-up</h3>
         </div>
         <p>The follow-up assessment is designed to evaluate the long-term effects of moxibustion.
            Upon completion of treatment, follow-up assessments will be conducted at the fourth,
            fifth, and sixth menstrual cycle after inclusion, lasting three menstrual cycles.
            In addition, patients will keep the daily dysmenorrhea diary and complete the CMSS
            and VAS measurements during every menstrual cycle in the follow-up period. Patients
            will send the relevant information to researchers immediately via email or short message
            service. To encourage participant compliance, we will show special solicitude for
            every participant and closely monitor the evolution of their illness.
         </p>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Statistical analysis plan</h3>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Data integrity</h4>
            </div>
            <p>No record can be missed or omitted in the original data source. Any corrections should
               be explained in the appended notes signed and dated by the physicians participating
               in the clinical trial; primary entries are not allowed to be changed. After the observation
               of a clinical case, case report form (CRF) files will be submitted to the project
               directors for verification and signing by supervisors.
            </p>
            <p>Data input will be done separately by two data collectors with computers and locked
               once the checking work is done. The data manager will clarify any questions regarding
               the CRF with the researchers through clinical supervisors. Researchers should answer
               any questions as soon as possible so that the data manager can conduct the modification,
               validation, and entry of the data.
            </p>
         </div>
         <div id="">
            <div tagx="st">
               <h4>Analysis</h4>
            </div>
            <p>A statistician blinded to the whole trial process will perform the statistical analysis
               using the SAS statistical software package (Version 9.1, SAS Institute Inc.) in the
               Computer Integrated Manufacturing System. For the evaluation of curative effect in
               this trial, the per protocol set (PPS) will be used. The full analysis set (FAS) is
               determined according to an intention-to-treat population; all patients who are randomized
               and receive at least one treatment session will be included in the analysis set. The
               PPS is defined as the patients who complete the study and do not have major protocol
               violations. Demographic data and other basic indicators will be analyzed to test the
               balance of the three groups at baseline. The main indicators and global indicators
               will be analyzed within the FAS and PPS. The results will be described with the mean,
               standard deviation, median, P25 (Percentile 25), P75 (Percentile75), maximum, and
               minimum values of the differences between the treatment period and the baseline period.
               Between-group differences will be tested using repeated measure analyses of variance.
               The accepted level of significance for all analyses was 
               <i>P</i> &lt;0.05. Considering that the efficacy might be affected by factors such as age, age
               of menarche, and course of disease, all factors will be considered as co-variants
               for covariance analysis or logistic regression analysis when comparisons among groups
               are made. Missing data will be replaced according to the principle of multiple imputations.
            </p>
         </div>
      </div>
      <div id="">
         <div tagx="st">
            <h3>Safety monitoring</h3>
         </div>
         <p>Possible adverse events (AEs) due to moxibustion include blisters, redness, itching,
            burns, and respiratory symptoms. All unexpected and unintended responses will be reported
            as AEs by the researcher at every visit, even if they are not necessarily related
            to moxibustion intervention. The AEs will be carefully recorded in the CRF by the
            corresponding research staff.
         </p>
      </div>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Discussion</h2>
      </div>
      <p>This proposed trial is a randomized, controlled clinical trial with separation of
         the practitioner, assessor, and statistician. The aims of this trial are to evaluate
         the efficacy and safety of moxibustion for treating PD, and to identify the optimal
         interventional time of moxibustion for PD treatment.
      </p>
      <p>The form of moxibustion used in this trial will be suspended moxibustion treatment.
         When suspended moxibustion is applied to acupoints, the patient will have non-local
         or non-superficial heat sensation, such as penetrating heat, expanding heat, and transmitting
         heat, as 
         <i>DeQi</i> appears. Selection of optimal acupoints for PD plays an important role in moxibustion
         treatment effectiveness. In practice, the treatment effect of moxibustion is affected
         by many other influential factors, including the intensity of heat stimulation, the
         ingredients of the moxa pillar, and the moxibustion sensations experienced. The most
         important factor contributing to the effectiveness of moxibustion is thought to be
         the selection of proper interventional time. However, in existing studies, interventional
         timing of moxibustion was not included as a key variant to be assessed.
      </p>
      <p>In another undergoing study, we mainly focused on the effectiveness of moxibustion
         for pain relief in PD, which can be referred to the published protocol 
         <span tagx="abbrgrp">
            <span tagx="abbr">32</span>
         </span>. As to the current one, it is conceived on the basis of the former one. As indicated
         by the results from the initial analysis, moxibustion is effective for PD pain management;
         thus we want to further assess the impact of intervention time of moxibustion on the
         outcome of treating PD, so as the physiological tests’ change by treatment. In clinical
         practice, moxibustion treatment for PD can also be differed by the intervention timing
         in China, and there is no relative study on this focus. Thus we carried out the present
         study as a continuum which is reported by the current protocol. It is anticipated
         that the result may demonstrate the optimal interventional timing for PD and further
         extend our understanding of intervention from a chrono-therapeutic perspective, which
         will be highlights of our further reports. Moreover, the present study that was designed
         in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement,
         and guidelines will provide useful information to guide the clinical practice of moxibustion
         for PD.
      </p>
      <p>In addition, our study may also have the following strengths which will be potential
         points of discussion in the final reports. The dysmenorrhea diaries will be used to
         record the symptoms and management of menstrual pain in every menstrual cycle; these
         diaries are important for quality monitoring of the recurrence of new PD episodes.
         Besides the evident physical concerns, PD may be particularly disruptive to adolescent
         girls and women who experience mood fluctuations, such as depression or anxiety. There
         is increasing evidence that psychological disorders coexist with dysmenorrhea, and
         these conditions may synchronize with menstrual pain. The question remains whether
         anxiety and depression make women prone to suffering from dysmenorrhea, or whether
         dysmenorrhea causes anxiety and depression. We believe that women with mood changes
         tend to have lowered pain thresholds compared with mentally healthy women. Anxiety
         and depression disrupt patients’ experiences, expressions, behaviors, and pain-coping
         responses. Therefore, a better understanding of the relationship between psychological
         characteristics and PD is crucial to the assessment of the effectiveness of moxibustion
         as a treatment for PD. Hence, we will apply the SAS and the SDS to examine the link
         between PD and psychological symptoms of depression and anxiety among dysmenorrhea
         sufferers.
      </p>
      <p>On the other hand, there are also limitations to this study. Concealment is the most
         critical factor in the allocation process, with a high risk of bias possibly generated
         by unconcealed allocation 
         <span tagx="abbrgrp">
            <span tagx="abbr">33</span>
         </span>. One limitation of this study is the possibility of a high risk of bias regarding
         blinding, as the waiting list group will be used as a control instead of a group receiving
         a sham procedure. Another limitation is that as moxibustion treatment will begin five
         to seven days before menstruation or at the onset of pain, the treatment may interfere
         with the menstrual period; treatment may cause menstruation to occur one or two days
         sooner or later than the usual cycle. Therefore, it may be difficult to predict an
         exact menstruation start date for the patients, and this may affect the therapeutic
         effect.
      </p>
      <p>It is believed that this trial will provide good evidence to demonstrate the efficacy
         and safety of moxibustion for patients with PD. Moreover, it will be of great significance
         for clinical practice to identify an optimal moxibustion treatment time for PD.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Trial status</h2>
      </div>
      <p>The trial is currently in the recruitment phase. Participant recruitment started in
         June 2014, and is expected to end in September 2015.
      </p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Abbreviations</h2>
      </div>
      <p>CMSS: Cox Menstrual Symptom Scale</p>
      <p>CRF: Case report form</p>
      <p>FAS: Full analysis set</p>
      <p>IRB: Institutional Review Board</p>
      <p>PD: Primary dysmenorrhea</p>
      <p>PPS: Per protocol set</p>
      <p>RCT: Randomized controlled trial</p>
      <p>RSS: Cox Retrospective Symptom Scale</p>
      <p>SAS: Self-rating Anxiety Scale</p>
      <p>SDS: Self-rating Depression Scale</p>
      <p>TCM: Traditional Chinese Medicine</p>
      <p>VAS: Visual analogue scale</p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Competing interests</h2>
      </div>
      <p>The authors declare that they have no competing interests.</p>
   </div>
   <div id="">
      <div tagx="st">
         <h2>Authors’ contributions</h2>
      </div>
      <p>JY and SYY contributed equally to this article. FRL and JY conceived this trial and
         participated in the design of this trial. JY, SYY, XW, and YPH participated in the
         design of the trial and drafted the manuscript. JL and JPC planed data analysis. LXL
         and MXY participated in the design of this trial and helped in drafting the manuscript.
         XL, YXW, XZC, QHZ, and LHZ recruited participants from clinics and universities. All
         authors read and approved the final manuscript.
      </p>
   </div>
   <div tagx="bm">
      <div tagx="ack">
         <div id="">
            <div tagx="st">
               <h2>Acknowledgments</h2>
            </div>
            <p>We would like to express our gratitude to the outpatient Departments of Acupuncture,
               Gynecology, and General Practice in the Third Affiliated Hospital of Chengdu University
               of Traditional Chinese Medicine, for their full cooperation and material support.
            </p>
            <p>This trial was financially supported by the National Basic Research Program for development
               (the ‘973 Program’) with grant number 2012CB518501, support program of the Science
               and Technology Department of Sichuan Province with grant number: 2012SZ0170, and program
               of the National Natural Science Foundation of China for Young Scientists, with grant
               number: 81303060.
            </p>
         </div>
      </div>
      <div tagx="refgrp">
         <div tagx="bibl">
            <div tagx="title">
               <p>Primary dysmenorrhoea</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Kennedy</span>
                  <span tagx="fnm">S</span>
               </li>
            </ul>
            <span tagx="source">Lancet</span>
            <span tagx="pubdate">1997</span>
            <span tagx="volume">349</span>
            <span tagx="issue">9059</span>
            <span tagx="fpage">1116</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S0140-6736(05)63018-8</span>
                  <span tagx="pubid">9113008</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>The burden and determinants of dysmenorrhoea: a population‐based survey of 2262 women
                  in Goa
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Patel</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Tanksale</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sahasrabhojanee</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gupte</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Nevrekar</span>
                  <span tagx="fnm">P</span>
               </li>
            </ul>
            <span tagx="source">India Br J Obstet Gynaecol</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">113</span>
            <span tagx="issue">4</span>
            <span tagx="fpage">453</span>
            <span tagx="lpage">63</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1471-0528.2006.00874.x</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>The prevalence and risk factors of dysmenorrhea</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ju</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jones</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Mishra</span>
                  <span tagx="fnm">G</span>
               </li>
            </ul>
            <span tagx="source">Epidemiol Rev</span>
            <span tagx="pubdate">2014</span>
            <span tagx="volume">36</span>
            <span tagx="issue">1</span>
            <span tagx="fpage">104</span>
            <span tagx="lpage">13</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1093/epirev/mxt009</span>
                  <span tagx="pubid">24284871</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Lea R: Prevalence of primary dysmenorrhea in Canada</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Burnett</span>
                  <span tagx="fnm">MA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Antao</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Black</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Feldman</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Grenville</span>
                  <span tagx="fnm">A</span>
               </li>
            </ul>
            <span tagx="source">J Obstet Gynaecol Can</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">27</span>
            <span tagx="issue">8</span>
            <span tagx="fpage">765</span>
            <span tagx="lpage">70</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">16287008</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Dysmenorrhea</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">French</span>
                  <span tagx="fnm">L</span>
               </li>
            </ul>
            <span tagx="source">Am Fam Physician</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">71</span>
            <span tagx="issue">2</span>
            <span tagx="fpage">285</span>
            <span tagx="lpage">91</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">15686299</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Johnson SR: The natural history of primary dysmenorrhoea: a longitudinal study</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Weissman</span>
                  <span tagx="fnm">AM</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hartz</span>
                  <span tagx="fnm">AJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hansen</span>
                  <span tagx="fnm">MD</span>
               </li>
            </ul>
            <span tagx="source">Br J Obstet Gynaecol</span>
            <span tagx="pubdate">2004</span>
            <span tagx="volume">111</span>
            <span tagx="issue">4</span>
            <span tagx="fpage">345</span>
            <span tagx="lpage">52</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1471-0528.2004.00090.x</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge
                  of treatment
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Hillen</span>
                  <span tagx="fnm">TI</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Grbavac</span>
                  <span tagx="fnm">SL</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Johnston</span>
                  <span tagx="fnm">PJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Straton</span>
                  <span tagx="fnm">JA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Keogh</span>
                  <span tagx="fnm">JM</span>
               </li>
            </ul>
            <span tagx="source">J Adolesc Health</span>
            <span tagx="pubdate">1999</span>
            <span tagx="volume">25</span>
            <span tagx="issue">1</span>
            <span tagx="fpage">40</span>
            <span tagx="lpage">5</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S1054-139X(98)00147-5</span>
                  <span tagx="pubid">10418884</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A survey of adolescent dysmenorrhea and premenstrual symptom frequency: a model program
                  for prevention, detection and treatment
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Wilson</span>
                  <span tagx="fnm">CA</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Keye</span>
                  <span tagx="fnm">WR</span>
                  <div tagx="suf">Jr</div>
               </li>
            </ul>
            <span tagx="source">J Adolesc Health Care</span>
            <span tagx="pubdate">1989</span>
            <span tagx="volume">10</span>
            <span tagx="issue">4</span>
            <span tagx="fpage">317</span>
            <span tagx="lpage">22</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/0197-0070(89)90065-X</span>
                  <span tagx="pubid">2786516</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Li Wan Po A</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zhang</span>
                  <span tagx="fnm">W</span>
               </li>
            </ul>
            <span tagx="source">Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review Br J Obstet
               Gynaecol
            </span>
            <span tagx="pubdate">1998</span>
            <span tagx="volume">105</span>
            <span tagx="issue">7</span>
            <span tagx="fpage">780</span>
            <span tagx="lpage">9</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Vecchio TJ: Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Morrison</span>
                  <span tagx="fnm">JC</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ling</span>
                  <span tagx="fnm">FW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Forman</span>
                  <span tagx="fnm">EK</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bates</span>
                  <span tagx="fnm">GW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Blake</span>
                  <span tagx="fnm">PG</span>
               </li>
            </ul>
            <span tagx="source">South Med J</span>
            <span tagx="pubdate">1980</span>
            <span tagx="volume">73</span>
            <span tagx="issue">8</span>
            <span tagx="fpage">999</span>
            <span tagx="lpage">1002</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1097/00007611-198008000-00014</span>
                  <span tagx="pubid">6996107</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Systematic review of clinical trials of acupuncture‐related therapies for primary
                  dysmenorrhea
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Yang</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Liu</span>
                  <span tagx="fnm">CZ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chen</span>
                  <span tagx="fnm">X</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ma</span>
                  <span tagx="fnm">LX</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Xie</span>
                  <span tagx="fnm">JP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Guo</span>
                  <span tagx="fnm">NN</span>
               </li>
            </ul>
            <span tagx="source">Acta Obstet Gynecol Scand</span>
            <span tagx="pubdate">2008</span>
            <span tagx="volume">87</span>
            <span tagx="issue">11</span>
            <span tagx="fpage">1114</span>
            <span tagx="lpage">22</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1080/00016340802443798</span>
                  <span tagx="pubid">18951224</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Caesarean section for non-medical reasons at term</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lavender</span>
                  <span tagx="fnm">T</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hofmeyr</span>
                  <span tagx="fnm">GJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Neilson</span>
                  <span tagx="fnm">JP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kingdon</span>
                  <span tagx="fnm">C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Gyte</span>
                  <span tagx="fnm">GM</span>
               </li>
            </ul>
            <span tagx="source">Cochrane Database Syst Rev</span>
            <span tagx="pubdate">2012</span>
            <span tagx="volume">14</span>
            <span tagx="issue">3</span>
            <div tagx="note">Article ID CD004660</div>
         </div>
         <div tagx="bibl">
            <ul tagx="insg">
               <li tagx="ins">
                  <p>World Health Organization</p>
               </li>
            </ul>
            <span tagx="source">WHO international standard terminologies on traditional medicine in the western pacific
               region
            </span>
            <div tagx="publisher">World Health Organization, Western Pacific Region</div>
            <span tagx="pubdate">2007</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Abdominal acupuncture combined with moxibustion for pelvic inflammation</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Jianhua</span>
                  <span tagx="fnm">C</span>
               </li>
            </ul>
            <span tagx="source">J Acupunct Tuina Sci</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">9</span>
            <span tagx="issue">5</span>
            <span tagx="fpage">301</span>
            <span tagx="lpage">3</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1007/s11726-011-0537-x</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Modern progress of mechanism of moxibustion therapy</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zhang</span>
                  <span tagx="fnm">J-F</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wu</span>
                  <span tagx="fnm">Y-C</span>
               </li>
            </ul>
            <span tagx="source">J Acupunct Tuina Sci</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">4</span>
            <span tagx="issue">5</span>
            <span tagx="fpage">257</span>
            <span tagx="lpage">60</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1007/s11726-005-0257-1</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Analysis on therapeutic effect of substance-partitioned moxibustion at Guanyuan (CV
                  4) and shenque (CV 8) for treatment of primary dysmenorrhea of cold-damp type
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Li</span>
                  <span tagx="fnm">W</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Liu</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Sun</span>
                  <span tagx="fnm">L</span>
               </li>
            </ul>
            <span tagx="source">Zhongguo Zhen Jiu</span>
            <span tagx="pubdate">2006</span>
            <span tagx="volume">26</span>
            <span tagx="issue">7</span>
            <span tagx="fpage">481</span>
            <span tagx="lpage">2</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">16903598</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Application of fuzzy comprehensive evaluation technique in CAPP</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Yang</span>
                  <span tagx="fnm">X</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Liu</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <span tagx="source">Mach Tool Hydraulics</span>
            <span tagx="pubdate">2009</span>
            <span tagx="volume">2</span>
            <span tagx="issue">051</span>
            <span tagx="fpage">153</span>
            <span tagx="lpage">5</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Moxibustion for ulcerative colitis: a systematic review and meta-analysis</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">D-H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kim</span>
                  <span tagx="fnm">J-I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">MS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Choi</span>
                  <span tagx="fnm">T-Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Choi</span>
                  <span tagx="fnm">S-M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ernst</span>
                  <span tagx="fnm">E</span>
               </li>
            </ul>
            <span tagx="source">BMC Gastroenterol</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">10</span>
            <span tagx="issue">1</span>
            <span tagx="fpage">36</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1186/1471-230X-10-36</span>
                  <span tagx="pubid">20374658</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Moxibustion for stroke rehabilitation systematic review</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">MS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Shin</span>
                  <span tagx="fnm">B-C</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kim</span>
                  <span tagx="fnm">J-I</span>
               </li>
               <div tagx="etal"></div>
            </ul>
            <span tagx="source">Stroke</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">41</span>
            <span tagx="issue">4</span>
            <span tagx="fpage">817</span>
            <span tagx="lpage">20</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1161/STROKEAHA.109.566851</span>
                  <span tagx="pubid">20150551</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Moxibustion for treating menopausal hot flashes: a randomized clinical trial</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Park</span>
                  <span tagx="fnm">J-E</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Jung</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kim</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Kang</span>
                  <span tagx="fnm">K</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Choi</span>
                  <span tagx="fnm">J</span>
               </li>
            </ul>
            <span tagx="source">Menopause</span>
            <span tagx="pubdate">2009</span>
            <span tagx="volume">16</span>
            <span tagx="issue">4</span>
            <span tagx="fpage">660</span>
            <span tagx="lpage">5</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1097/gme.0b013e318198cdf7</span>
                  <span tagx="pubid">19293729</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Han C-h, Ernst E: Effects of moxibustion for constipation treatment: a systematic
                  review of randomized controlled trials
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">MS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Choi</span>
                  <span tagx="fnm">T-Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Park</span>
                  <span tagx="fnm">J-E</span>
               </li>
            </ul>
            <span tagx="source">Chinese Med</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">5</span>
            <span tagx="issue">1</span>
            <span tagx="fpage">28</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1186/1749-8546-5-28</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Moxibustion for hypertension: a systematic review</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Kim</span>
                  <span tagx="fnm">J-I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Choi</span>
                  <span tagx="fnm">J-Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">H</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lee</span>
                  <span tagx="fnm">MS</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ernst</span>
                  <span tagx="fnm">E</span>
               </li>
            </ul>
            <span tagx="source">BMC Cardiovasc Disord</span>
            <span tagx="pubdate">2010</span>
            <span tagx="volume">10</span>
            <span tagx="fpage">33</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1186/1471-2261-10-33</span>
                  <span tagx="pubid">20602794</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effects of single moxibustion on cutaneous blood vessel and microvascular permeability
                  in mice
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Okazaki</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Aizawa</span>
                  <span tagx="fnm">S</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yamauchi</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Oguchi</span>
                  <span tagx="fnm">K</span>
               </li>
            </ul>
            <span tagx="source">Am J Chin Med</span>
            <span tagx="pubdate">1990</span>
            <span tagx="volume">18</span>
            <span tagx="issue">03n04</span>
            <span tagx="fpage">121</span>
            <span tagx="lpage">30</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1142/S0192415X90000162</span>
                  <span tagx="pubid">2270846</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Du D-Q:A clinical trial of acupuncture about time-varying treatment and points selection
                  in primary dysmenorrhea
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Ma</span>
                  <span tagx="fnm">Y-X</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ye</span>
                  <span tagx="fnm">X-N</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Liu</span>
                  <span tagx="fnm">C-Z</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Cai</span>
                  <span tagx="fnm">P-Y</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Li</span>
                  <span tagx="fnm">Z-F</span>
               </li>
            </ul>
            <span tagx="source">J Ethnopharmacol</span>
            <span tagx="pubdate">2013</span>
            <span tagx="volume">148</span>
            <span tagx="issue">2</span>
            <span tagx="fpage">498</span>
            <span tagx="lpage">504</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.jep.2013.04.045</span>
                  <span tagx="pubid">23684618</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Feldman K,: Primary dysmenorrhea consensus guideline</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Lefebvre</span>
                  <span tagx="fnm">G</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Pinsonneault</span>
                  <span tagx="fnm">O</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Antao</span>
                  <span tagx="fnm">V</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Black</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Burnett</span>
                  <span tagx="fnm">M</span>
               </li>
            </ul>
            <span tagx="source">J Obstet Gynaecol Can</span>
            <span tagx="pubdate">2005</span>
            <span tagx="volume">27</span>
            <span tagx="issue">12</span>
            <span tagx="fpage">1117</span>
            <span tagx="lpage">46</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">16524531</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Primary dysmenorrhoea: A comparative study on Australian and Chinese women</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zhu</span>
                  <span tagx="fnm">X</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bensoussan</span>
                  <span tagx="fnm">A</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zhu</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Qian</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Xu</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zhou</span>
                  <span tagx="fnm">C</span>
               </li>
            </ul>
            <span tagx="source">Complement Ther Med</span>
            <span tagx="pubdate">2009</span>
            <span tagx="volume">17</span>
            <span tagx="issue">3</span>
            <span tagx="fpage">155</span>
            <span tagx="lpage">60</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/j.ctim.2008.10.001</span>
                  <span tagx="pubid">19398069</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Randomized controlled study on the analgesic effect of superficial needling plus electrostimulation
                  of sanyinjiao (SP6) for primary dysmenorrhea
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zhi</span>
                  <span tagx="fnm">L</span>
               </li>
            </ul>
            <span tagx="source">Zhen Ci Yan Jiu</span>
            <span tagx="pubdate">2007</span>
            <span tagx="volume">32</span>
            <span tagx="issue">5</span>
            <span tagx="fpage">342</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">18050629</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Behavioral treatment parameters with primary dysmenorrhea</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Cox</span>
                  <span tagx="fnm">DJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Meyer</span>
                  <span tagx="fnm">RG</span>
               </li>
            </ul>
            <span tagx="source">J Behav Med</span>
            <span tagx="pubdate">1978</span>
            <span tagx="volume">1</span>
            <span tagx="issue">3</span>
            <span tagx="fpage">297</span>
            <span tagx="lpage">310</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1007/BF00846681</span>
                  <span tagx="pubid">40034</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Yang H: Immediate analgesia effect of single point acupuncture in primary dysmenorrhea:
                  a randomized controlled trial
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Liu</span>
                  <span tagx="fnm">CZ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Xie</span>
                  <span tagx="fnm">JP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Wang</span>
                  <span tagx="fnm">LP</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Zheng</span>
                  <span tagx="fnm">YY</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Ma</span>
                  <span tagx="fnm">ZB</span>
               </li>
            </ul>
            <span tagx="source">Pain Med</span>
            <span tagx="pubdate">2011</span>
            <span tagx="volume">12</span>
            <span tagx="issue">2</span>
            <span tagx="fpage">300</span>
            <span tagx="lpage">7</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1111/j.1526-4637.2010.01017.x</span>
                  <span tagx="pubid">21166767</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Self-rating depression scale in an outpatient clinic: further validation of the SDS</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zung</span>
                  <span tagx="fnm">WW</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Richards</span>
                  <span tagx="fnm">CB</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Short</span>
                  <span tagx="fnm">MJ</span>
               </li>
            </ul>
            <span tagx="source">Arch Gen Psychiatry</span>
            <span tagx="pubdate">1965</span>
            <span tagx="volume">13</span>
            <span tagx="issue">6</span>
            <span tagx="fpage">508</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1001/archpsyc.1965.01730060026004</span>
                  <span tagx="pubid">4378854</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>A rating instrument for anxiety disorders</p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Zung</span>
                  <span tagx="fnm">WW</span>
               </li>
            </ul>
            <span tagx="source">Psychosomatics</span>
            <span tagx="pubdate">1971</span>
            <span tagx="volume">12</span>
            <span tagx="issue">6</span>
            <span tagx="fpage">371</span>
            <span tagx="lpage">9</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1016/S0033-3182(71)71479-0</span>
                  <span tagx="pubid">5172928</span>
               </div>
            </div>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Effectiveness study of moxibustion on pain relief in primary dysmenorrhea: study protocol
                  of a randomized controlled trial
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Yang</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chen</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Lao</span>
                  <span tagx="fnm">L</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Yang</span>
                  <span tagx="fnm">M</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chen</span>
                  <span tagx="fnm">J</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Bo</span>
                  <span tagx="fnm">L</span>
               </li>
            </ul>
            <span tagx="source">Evid Based Complement Alternat Med</span>
            <span tagx="pubdate">2014</span>
            <span tagx="volume">2014</span>
            <span tagx="fpage">1</span>
            <span tagx="lpage">6</span>
         </div>
         <div tagx="bibl">
            <div tagx="title">
               <p>Empirical evidence of bias: dimensions of methodological quality associated with estimates
                  of treatment effects in controlled trials
               </p>
            </div>
            <ul tagx="aug">
               <li tagx="au">
                  <span tagx="snm">Schulz</span>
                  <span tagx="fnm">KF</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Chalmers</span>
                  <span tagx="fnm">I</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Hayes</span>
                  <span tagx="fnm">RJ</span>
               </li>
               <li tagx="au">
                  <span tagx="snm">Altman</span>
                  <span tagx="fnm">DG</span>
               </li>
            </ul>
            <span tagx="source">JAMA</span>
            <span tagx="pubdate">1995</span>
            <span tagx="volume">273</span>
            <span tagx="issue">5</span>
            <span tagx="fpage">408</span>
            <span tagx="lpage">12</span>
            <div tagx="xrefbib">
               <div tagx="pubidlist">
                  <span tagx="pubid">10.1001/jama.1995.03520290060030</span>
                  <span tagx="pubid">7823387</span>
               </div>
            </div>
         </div>
      </div>
   </div>
</html>